Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study

    NEXT STORY
    Fortress Biotech Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
    PREV STORY
    Calithera Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    第19回世界肺癌学会議では最大数の参加者を迎え、研究者、肺癌の生存者、アドボケート、医師が集合して肺癌の研究、治療、アドボカシーについて話し合う

    トロント発 , Sept. 26, 2018 (GLOBE NEWSWIRE) -- カナダのトロントで開催されている国際肺癌学会 (International Association for the Study ...

    author_avatar
    NASDAQ Market News

    Bavarian Nordic Announces First Half 2018 Results

    COPENHAGEN, Denmark, August 16, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced ...

    author_avatar
    NASDAQ Market News

    Clearlake Capital-Backed Provation Names Bill Franck Chief Sales Officer (CSO)

    author_avatar
    NASDAQ Market News